TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hua Medicine ( (HK:2552) ) has provided an update.
Hua Medicine announced the resignation of Dr. Fangxin Li as a non-executive director and a member of the Remuneration Committee, effective June 25, 2025, due to personal work arrangements. The company expressed gratitude for Dr. Li’s contributions, and his departure is not expected to impact the company’s operations or shareholder interests.
More about Hua Medicine
Hua Medicine is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for diabetes and related metabolic diseases.
Average Trading Volume: 5,106,420
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.76B
For an in-depth examination of 2552 stock, go to TipRanks’ Overview page.